Vaccination News

NEW YORK — As vaccination coverage declines globally, pediatricians need to prepare to encounter more measles cases in their communities, according to a presentation at the Infectious Diseases in Children Symposium.

NEW YORK — In this video at the Infectious Diseases in Children Symposium, Catherine Mary Healy, MBBCh, describes what she called “an exciting time” for meningococcal vaccines.

Measles cases increased globally by 20% in 2023, and roughly 22 million children missed their first measles vaccine dose, according to the CDC and WHO’s annual global measles report.

Researchers presented data at IDWeek showing that socioeconomic vulnerability and race can negatively impact vaccine uptake.

Higher disease activity and medication reduction at COVID-19 vaccination increase the risk for subsequent flares in patients with rheumatic and musculoskeletal diseases, according to data published in Annals of the Rheumatic Diseases.

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.

A CDC advisory committee on Thursday voted unanimously to “harmonize” serogroup B meningococcal vaccine recommendations for healthy adolescents and young adults and children who have a higher risk for infection.

The simultaneous administration of adjuvant zoster and influenza vaccines posed no additional safety risks in older adults, results from a randomized study showed.